Author

Omar H

Professor, College of Pharmacy, University of Sharjah and Beni-Suef University (on leave) - Cited by 3,603 - Pharmacology - Molecular Pharmacology - Cancer Research

Biography

Omar H is currently working as a Professor in the Department of Endemic Medicine. His research interests includes biochemistry, hepatology, endemic medicine. He is serving as an editorial member and reviewer of several international reputed journals. He has successfully completed his  Administrative responsibilities. Omar H has authored of many research articles/books related to Endemic Medicine.  
Title
Cited by
Year
Ferroptosis: An emerging approach for targeting cancer stem cells and drug resistance
SM Elgendy, SK Alyammahi, DW Alhamad, SM Abdin, HA OmarCritical Reviews in Oncology/Hematology 155, 103095, 2020202
75
2020
The dynamic association between COVID-19 and chronic disorders: an updated insight into prevalence, mechanisms and therapeutic modalities
SK Alyammahi, SM Abdin, DW Alhamad, SM Elgendy, AT Altell, HA OmarInfection, Genetics and Evolution 87, 104647, 2021202
68
2021
Tackling the cytokine storm in COVID-19, challenges and hopes
SM Abdin, SM Elgendy, SK Alyammahi, DW Alhamad, HA OmarLife Sciences 257, 118054, 2020202
68
2020
Bee pollen: Current status and therapeutic potential
SAM Khalifa, MH Elashal, N Yosri, M Du, SG Musharraf, L Nahar, ...Nutrients 13 (6), 1876, 2021202
64
2021
Recent advances with alkaline phosphatase isoenzymes and their inhibitors
DM Zaher, MI El‐Gamal, HA Omar, SN Aljareh, SA Al‐Shamma, AJ Ali, ...Archiv der Pharmazie 353 (5), e2000011, 2020202
57
2020
Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells
SM Abdin, MF Tolba, DM Zaher, HA OmarChemico-Biological Interactions 340, 109450, 2021202
25
2021
22
2020
Modulating NF‐κB, MAPK, and PI3K/AKT signaling by ergothioneine attenuates iron overload‐induced hepatocellular injury in rats
SA Salama, HA OmarJournal of Biochemical and Molecular Toxicology 35 (5), e22729, 2021202
19
2021
Gliclazide attenuates acetic acid-induced colitis via the modulation of PPARγ, NF-κB and MAPK signaling pathways
ESA Arafa, WR Mohamed, DM Zaher, HA OmarToxicology and applied pharmacology 391, 1149, 2020202
19
2020
CCDC167 as a potential therapeutic target and regulator of cell cycle-related networks in breast cancer
PS Chen, HP Hsu, NN Phan, MC Yen, FW Chen, YW Liu, FP Lin, SY Feng, ...Aging (Albany NY) 13 (3), 4157, 2021202
19
2021
Effective targeting of breast cancer cells (MCF7) via novel biogenic synthesis of gold nanoparticles using cancer-derived metabolites
SSM Soliman, TB Alhamidi, S Abdin, AM Almehdi, MH Semreen, ...PloS one 15 (10), e0240156, 2020202
14
2020
PRMT5 selective inhibitor enhances therapeutic efficacy of cisplatin in lung cancer cells
K Bajbouj, RK Ramakrishnan, M Saber-Ayad, HA Omar, ...International Journal of Molecular Sciences 22 (11), 61, 2021202
13
2021
Potential targeting of Hep3B liver cancer cells by lupeol isolated from Avicennia marina
LM Eldohaji, B Fayed, AM Hamoda, M Ershaid, S Abdin, TB Alhamidi, ...Archiv der Pharmazie 354 (9), 2100120, 2021202
11
2021
Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative …
RM Sbenati, SO Zaraei, MI El-Gamal, HS Anbar, H Tarazi, MM Zoghbor, ...European journal of medicinal chemistry 210, 3081, 2021202
11
2021
The use of new quinazolinone derivative and doxorubicin loaded solid lipid nanoparticles in reversing drug resistance in experimental cancer cell lines: A systematic study
SF El-Menshawe, OM Sayed, HA Abou Taleb, MA Saweris, DM Zaher, ...Journal of Drug Delivery Science and Technology 56, 101569, 2020202
11
2020
Discovery of novel small-molecule inhibitors of SARS-CoV-2 main protease as potential leads for COVID-19 treatment
A Manandhar, V Srinivasulu, M Hamad, H Tarazi, H Omar, DJ Colussi, ...Journal of Chemical Information and Modeling 61 (9), 4745-4757, 2021202
10
2021
Comparative sphingolipidomic analysis reveals significant differences between doxorubicin-sensitive and-resistance MCF-7 cells
ODA Shammout, NS Ashmawy, SB Shakartalla, AM Altaie, MH Semreen, ...PLoS One 16 (10), e0258363, 2021202
9
2021
8
2021
The protective role of etoricoxib against diethylnitrosamine/2-acetylaminofluorene-induced hepatocarcinogenesis in Wistar rats: The impact of NF-κB/COX-2/PGE2 signaling
G Ali, H Omar, F Hersi, A Abo-Youssef, O Ahmed, W MohamedCurrent Molecular Pharmacology 15 (1), 252-262, 2022202
8
2022
Antibacterial activity of small molecules which eradicate methicillin-resistant Staphylococcus aureus persisters
M Hamad, F Al-Marzooq, V Srinivasulu, HA Omar, A Sulaiman, DM Zaher, ...Frontiers in microbiology 13, 823394, 2022202
7
2022